Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Study investigates statins and ACE inhibitors on adolescents with diabetes

  • Comment
A study is to determine whether statins and ACE inhibitors can reduce the risk of adolescents developing type I diabetes later in life.

Health charities Diabetes UK, the British Heart Foundation and the Juvenile Diabetes Research Foundation are funding the five year international study.

It is aimed to prevent high-risk 11-16 year olds developing heart and kidney disease.

Statins and ACA inhibitors have been shown to help reduce the risk of cardiovascular and kidney disease in adults with diabetes – but Cambridge University’s Adolescent Type I Diabetes Intervention Trial will be the first to focus on young people.

Researchers from the university’s Department of Paediatrics will coordinate with 11 other sites in the UK, Canada and Australia to find 500 adolescents with high protein levels in their urine, indicating risk of heart and kidney disease later in life.

They also want to find 400 subjects with lower protein levels at low or medium risk of developing diabetes-related conditions.

High risk groups will receive either statin and placebo, ACE inhibitor and placebo, both ACE inhibitor and statin, or placebo and placebo.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs